Global Biosimilar Insulin Industry Research Report 2020, Forecast to 2025

September 2020 | 105 pages | ID: G44CD5CF3B53EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Biosimilar Insulin market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Biosimilar Insulin is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Biosimilar Insulin industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Biosimilar Insulin by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Biosimilar Insulin market are discussed.

The market is segmented by types:

• Rapid Acting Insulins
• Short Acting Insulins
• Intermediate Insulins
• Long Lasting Insulins

It can be also divided by applications:

• Hospital
• Clinic
• Medical Center

And this report covers the historical situation, present status and the future prospects of the global Biosimilar Insulin market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Pfizer
• Samsung Bioepis
• Gan&Lee Pharmaceuticals
• Biogenomics
• Paras Biopharmaceuticals
• Eli Lilly
• Wockhardt
• Julphar Gulf Pharmaceutical Industries
• Geropharm
• Sedico
• Teva Pharmaceuticals

Report Includes:

• xx data tables and xx additional tables
• An overview of global Biosimilar Insulin market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Biosimilar Insulin market
• Profiles of major players in the industry, including Pfizer, Samsung Bioepis, Gan&Lee Pharmaceuticals, Biogenomics, Paras Biopharmaceuticals.....

Research Objectives

• To study and analyze the global Biosimilar Insulin consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Biosimilar Insulin market by identifying its various subsegments.
• Focuses on the key global Biosimilar Insulin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Biosimilar Insulin with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Biosimilar Insulin submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Biosimilar Insulin Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Biosimilar Insulin Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 BIOSIMILAR INSULIN INDUSTRY OVERVIEW

2.1 Global Biosimilar Insulin Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Biosimilar Insulin Global Import Market Analysis
  2.1.2 Biosimilar Insulin Global Export Market Analysis
  2.1.3 Biosimilar Insulin Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Rapid Acting Insulins
  2.2.2 Short Acting Insulins
  2.2.3 Intermediate Insulins
  2.2.4 Long Lasting Insulins
2.3 Market Analysis by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Medical Center
2.4 Global Biosimilar Insulin Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Biosimilar Insulin Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Biosimilar Insulin Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Biosimilar Insulin Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Biosimilar Insulin Manufacturer Market Share
  2.4.5 Top 10 Biosimilar Insulin Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Biosimilar Insulin Market
  2.4.7 Key Manufacturers Biosimilar Insulin Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Biosimilar Insulin Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Biosimilar Insulin Industry Impact
  2.7.1 How the Covid-19 is Affecting the Biosimilar Insulin Industry
  2.7.2 Biosimilar Insulin Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Biosimilar Insulin Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Biosimilar Insulin Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL BIOSIMILAR INSULIN MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Biosimilar Insulin Sales Market Share by Region
4.2 Global Biosimilar Insulin Revenue Market Share by Region (2015-2019)
4.3 Global Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Biosimilar Insulin Market Size Detail
  4.4.1 North America Biosimilar Insulin Sales Growth Rate (2015-2020)
  4.4.2 North America Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Biosimilar Insulin Market Size Detail
  4.5.1 Europe Biosimilar Insulin Sales Growth Rate (2015-2020)
  4.5.2 Europe Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Biosimilar Insulin Market Size Detail
  4.6.1 Japan Biosimilar Insulin Sales Growth Rate (2015-2020)
  4.6.2 Japan Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Biosimilar Insulin Market Size Detail
  4.7.1 China Biosimilar Insulin Sales Growth Rate (2015-2020)
  4.7.2 China Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL BIOSIMILAR INSULIN MARKET SEGMENT BY TYPE

5.1 Global Biosimilar Insulin Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Biosimilar Insulin Sales and Market Share by Type (2015-2020)
  5.1.2 Global Biosimilar Insulin Revenue and Market Share by Type (2015-2020)
5.2 Rapid Acting Insulins Sales Growth Rate and Price
  5.2.1 Global Rapid Acting Insulins Sales Growth Rate (2015-2020)
  5.2.2 Global Rapid Acting Insulins Price (2015-2020)
5.3 Short Acting Insulins Sales Growth Rate and Price
  5.3.1 Global Short Acting Insulins Sales Growth Rate (2015-2020)
  5.3.2 Global Short Acting Insulins Price (2015-2020)
5.4 Intermediate Insulins Sales Growth Rate and Price
  5.4.1 Global Intermediate Insulins Sales Growth Rate (2015-2020)
  5.4.2 Global Intermediate Insulins Price (2015-2020)
5.5 Long Lasting Insulins Sales Growth Rate and Price
  5.5.1 Global Long Lasting Insulins Sales Growth Rate (2015-2020)
  5.5.2 Global Long Lasting Insulins Price (2015-2020)

6 GLOBAL BIOSIMILAR INSULIN MARKET SEGMENT BY APPLICATION

6.1 Global Biosimilar InsulinSales Market Share by Application (2015-2020)
6.2 Hospital Sales Growth Rate (2015-2020)
6.3 Clinic Sales Growth Rate (2015-2020)
6.4 Medical Center Sales Growth Rate (2015-2020)

7 GLOBAL BIOSIMILAR INSULIN MARKET FORECAST

7.1 Global Biosimilar Insulin Sales, Revenue Forecast
  7.1.1 Global Biosimilar Insulin Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Biosimilar Insulin Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Biosimilar Insulin Price and Trend Forecast (2020-2025)
7.2 Global Biosimilar Insulin Sales Forecast by Region (2020-2025)
  7.2.1 North America Biosimilar Insulin Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Biosimilar Insulin Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Biosimilar Insulin Production, Revenue Forecast (2020-2025)
  7.2.4 China Biosimilar Insulin Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF BIOSIMILAR INSULIN INDUSTRY KEY MANUFACTURERS

8.1 Pfizer
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Pfizer Biosimilar Insulin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Pfizer News
8.2 Samsung Bioepis
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Samsung Bioepis Biosimilar Insulin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Samsung Bioepis News
8.3 Gan&Lee Pharmaceuticals
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Gan&Lee Pharmaceuticals Biosimilar Insulin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Gan&Lee Pharmaceuticals News
8.4 Biogenomics
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Biogenomics Biosimilar Insulin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Biogenomics News
8.5 Paras Biopharmaceuticals
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Paras Biopharmaceuticals Biosimilar Insulin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Paras Biopharmaceuticals News
8.6 Eli Lilly
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Eli Lilly Biosimilar Insulin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Eli Lilly News
8.7 Wockhardt
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Wockhardt Biosimilar Insulin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Wockhardt News
8.8 Julphar Gulf Pharmaceutical Industries
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Julphar Gulf Pharmaceutical Industries News
8.9 Geropharm
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 Geropharm Biosimilar Insulin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 Geropharm News
8.10 Sedico
  8.10.1 Company Details
  8.10.2 Product Information
  8.10.3 Sedico Biosimilar Insulin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.10.4 Main Business Overview
  8.10.5 Sedico News
8.11 Teva Pharmaceuticals
  8.11.1 Company Details
  8.11.2 Product Information
  8.11.3 Teva Pharmaceuticals Biosimilar Insulin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.11.4 Main Business Overview
  8.11.5 Teva Pharmaceuticals News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Biosimilar Insulin Picture
Figure Research Programs/Design for This Report
Figure Global Biosimilar Insulin Market by Regions (2019)
Table Global Market Biosimilar Insulin Comparison by Regions (M USD) 2019-2025
Table Global Biosimilar Insulin Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Biosimilar Insulin by Type in 2019
Figure Rapid Acting Insulins Picture
Figure Short Acting Insulins Picture
Figure Intermediate Insulins Picture
Figure Long Lasting Insulins Picture
Table Global Biosimilar Insulin Sales by Application (2019-2025)
Figure Global Biosimilar Insulin Sales Market Share by Application in 2019
Figure Hospital Picture
Figure Clinic Picture
Figure Medical Center Picture
Table Global Biosimilar Insulin Sales by Manufacturer (2018-2020)
Figure Global Biosimilar Insulin Sales Market Share by Manufacturer in 2019
Table Global Biosimilar Insulin Revenue by Manufacturer (2018-2020)
Figure Global Biosimilar Insulin Revenue Market Share by Manufacturer in 2019
Table Global Biosimilar Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Biosimilar Insulin Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Biosimilar Insulin Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Biosimilar Insulin Market
Table Key Manufacturers Biosimilar Insulin Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Insulin
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Biosimilar Insulin Sales (K Units) by Region (2015-2020)
Table Global Biosimilar Insulin Sales Market Share by Region (2015-2019)
Figure Global Biosimilar Insulin Sales Market Share by Region (2015-2019)
Figure Global Biosimilar Insulin Sales Market Share by Region in 2018
Table Global Biosimilar Insulin Revenue (Million US$) by Region (2015-2020)
Table Global Biosimilar Insulin Revenue Market Share by Region (2015-2020)
Figure Global Biosimilar Insulin Revenue Market Share by Region (2015-2020)
Figure Global Biosimilar Insulin Revenue Market Share by Region in 2019
Table Global Biosimilar Insulin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Biosimilar Insulin Sales (K Units) Growth Rate (2015-2020)
Table North America Biosimilar Insulin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Biosimilar Insulin Sales (K Units) Growth Rate (2015-2020)
Table Europe Biosimilar Insulin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Biosimilar Insulin Sales (K Units) Growth Rate (2015-2020)
Table Japan Biosimilar Insulin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Biosimilar Insulin Sales (K Units) Growth Rate (2015-2020)
Table China Biosimilar Insulin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Biosimilar Insulin Sales by Type (2015-2020)
Table Global Biosimilar Insulin Sales Market Share by Type (2015-2020)
Figure Global Biosimilar Insulin Sales Market Share by Type in 2019
Table Global Biosimilar Insulin Revenue by Type (2015-2020)
Table Global Biosimilar Insulin Revenue Market Share by Type (2015-2020)
Figure Global Biosimilar Insulin Revenue Market Share by Type in 2019
Figure Global Rapid Acting Insulins Sales Growth Rate (2015-2020)
Figure Global Rapid Acting Insulins Price (2015-2020)
Figure Global Short Acting Insulins Sales Growth Rate (2015-2020)
Figure Global Short Acting Insulins Price (2015-2020)
Figure Global Intermediate Insulins Sales Growth Rate (2015-2020)
Figure Global Intermediate Insulins Price (2015-2020)
Figure Global Long Lasting Insulins Sales Growth Rate (2015-2020)
Figure Global Long Lasting Insulins Price (2015-2020)
Table Global Biosimilar Insulin Sales by Application (2015-2020)
Table Global Biosimilar Insulin Sales Market Share by Application (2015-2020)
Figure Global Biosimilar Insulin Sales Market Share by Application in 2019
Figure Global Hospital Sales Growth Rate (2015-2020)
Figure Global Clinic Sales Growth Rate (2015-2020)
Figure Global Medical Center Sales Growth Rate (2015-2020)
Figure Global Biosimilar Insulin Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Biosimilar Insulin Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Biosimilar Insulin Price and Trend Forecast (2020-2025)
Table Global Biosimilar Insulin Sales (K Units) Forecast by Region (2020-2025)
Figure Global Biosimilar Insulin Production Market Share Forecast by Region (2020-2025)
Figure North America Biosimilar Insulin Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Biosimilar Insulin Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Biosimilar Insulin Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Biosimilar Insulin Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Biosimilar Insulin Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Biosimilar Insulin Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Biosimilar Insulin Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Biosimilar Insulin Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Pfizer Company Profile
Figure Biosimilar Insulin Product Picture and Specifications of Pfizer
Table Biosimilar Insulin Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pfizer Biosimilar Insulin Market Share (2018-2020)
Table Pfizer Main Business
Table Pfizer Recent Development
Table Samsung Bioepis Company Profile
Figure Biosimilar Insulin Product Picture and Specifications of Samsung Bioepis
Table Biosimilar Insulin Production, Price, Revenue and Gross Margin of 2018-2020
Figure Samsung Bioepis Biosimilar Insulin Market Share (2018-2020)
Table Samsung Bioepis Main Business
Table Samsung Bioepis Recent Development
Table Gan&Lee Pharmaceuticals Company Profile
Figure Biosimilar Insulin Product Picture and Specifications of Gan&Lee Pharmaceuticals
Table Biosimilar Insulin Production, Price, Revenue and Gross Margin of 2018-2020
Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Market Share (2018-2020)
Table Gan&Lee Pharmaceuticals Main Business
Table Gan&Lee Pharmaceuticals Recent Development
Table Biogenomics Company Profile
Figure Biosimilar Insulin Product Picture and Specifications of Biogenomics
Table Biosimilar Insulin Production, Price, Revenue and Gross Margin of 2018-2020
Figure Biogenomics Biosimilar Insulin Market Share (2018-2020)
Table Biogenomics Main Business
Table Biogenomics Recent Development
Table Paras Biopharmaceuticals Company Profile
Figure Biosimilar Insulin Product Picture and Specifications of Paras Biopharmaceuticals
Table Biosimilar Insulin Production, Price, Revenue and Gross Margin of 2018-2020
Figure Paras Biopharmaceuticals Biosimilar Insulin Market Share (2018-2020)
Table Paras Biopharmaceuticals Main Business
Table Paras Biopharmaceuticals Recent Development
Table Eli Lilly Company Profile
Figure Biosimilar Insulin Product Picture and Specifications of Eli Lilly
Table Biosimilar Insulin Production, Price, Revenue and Gross Margin of 2018-2020
Figure Eli Lilly Biosimilar Insulin Market Share (2018-2020)
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Wockhardt Company Profile
Figure Biosimilar Insulin Product Picture and Specifications of Wockhardt
Table Biosimilar Insulin Production, Price, Revenue and Gross Margin of 2018-2020
Figure Wockhardt Biosimilar Insulin Market Share (2018-2020)
Table Wockhardt Main Business
Table Wockhardt Recent Development
Table Julphar Gulf Pharmaceutical Industries Company Profile
Figure Biosimilar Insulin Product Picture and Specifications of Julphar Gulf Pharmaceutical Industries
Table Biosimilar Insulin Production, Price, Revenue and Gross Margin of 2018-2020
Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Market Share (2018-2020)
Table Julphar Gulf Pharmaceutical Industries Main Business
Table Julphar Gulf Pharmaceutical Industries Recent Development
Table Geropharm Company Profile
Figure Biosimilar Insulin Product Picture and Specifications of Geropharm
Table Biosimilar Insulin Production, Price, Revenue and Gross Margin of 2018-2020
Figure Geropharm Biosimilar Insulin Market Share (2018-2020)
Table Geropharm Main Business
Table Geropharm Recent Development
Table Sedico Company Profile
Figure Biosimilar Insulin Product Picture and Specifications of Sedico
Table Biosimilar Insulin Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sedico Biosimilar Insulin Market Share (2018-2020)
Table Sedico Main Business
Table Sedico Recent Development
Table Teva Pharmaceuticals Company Profile
Figure Biosimilar Insulin Product Picture and Specifications of Teva Pharmaceuticals
Table Biosimilar Insulin Production, Price, Revenue and Gross Margin of 2018-2020
Figure Teva Pharmaceuticals Biosimilar Insulin Market Share (2018-2020)
Table Teva Pharmaceuticals Main Business
Table Teva Pharmaceuticals Recent Development
Table of Appendix